Advances in LC platforms for drug discovery

Expert Opinion on Drug Discovery

Volumn 5, Issue 5, 2010, Pages 475-489

  Nicoli, Raul ^a   Martel, Sophie ^a   Rudaz, Serge ^a   Wolfender, Jean Luc ^a   Veuthey, Jean Luc ^a   Carrupt, Pierre Alain ^a   Guillarme, Davy ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Drug discovery; Drug metabolism; Drug permeability; LC; LC MS; Lipophilicity; PKa; UHPLC; UHPLC MS

Indexed keywords

DRUG METABOLISM; DRUG PENETRATION; DRUG RESEARCH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; LIPOPHILICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PKA; PRIORITY JOURNAL; REVIEW;

EID: 77951672073     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441003733874     Document Type: Review

References (100)

1. Bleicher KH, Bohm HJ, Muller K, Alanine AI. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2003;2:369-378
2. Mayr LM, Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol 2009;9:580-588
3. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005;4:206-220
4. Smith DA, van de Waterbeemd H. Pharmacokinetics and metabolism in early drug discovery. Curr Opin Chem Biol 1999;3:373-378
5. Kerns EH, Di L. Pharmaceutical profiling in drug discovery. Drug Discov Today 2003;8:316-323
6. Korfmacher WA. Principles and applications of LC-MS in new drug discovery. Drug Discov Today 2005;10:1357-1367
7. Wolfender JL, Queiroz EF, Hostettman K. The importance of hyphenated techniques in the discovery of new lead compounds from nature. Expert Opin Drug Discov 2006;1:237-260
8. Shin YG, van Breemen RB. Analysis and screening of combinatorial libraries using mass spectrometry. Biopharm Drug Dispos 2001;22:353-372
9. Mallis LM, Sarkahian AB, Kulishoff JM, Watts WL. Open-access liquid chromatography/mass spectrometry in a drug discovery environment. J Mass Spectrom 2002;37:889-896
10. Kassel DB. Applications of high-throughput ADME in drug discovery. Curr Opin Chem Biol 2004;8:339-345
11. Kerns EH. High throughput physicochemical profiling for drug discovery. J Pharm Sci 2001;90:1838-1858
12. Henchoz Y, Bard B, Guillarme D, et al. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution. Anal Bioanal Chem 2009;394:707-729
13. Martel S, Guillarme D, Henchoz Y, et al. Chromatographic approaches for measuring logP. In: Mannhold R, editor, Molecular drug properties: measurement and computation. Wiley-VCH, 2008
14. Russo R, Guillarme D, Nguyen DT, et al. Pharmaceutical applications on columns packed with sub-2μ m particles. J Chromatogr Sci 2008;46:199-208
15. Nguyen DT, Guillarme D, Rudaz S, Veuthey JL. Chromatographic behaviour and comparison of column packed with sub-2μ m stationary phases in liquid chromatography. J Chromatogr A 2006;1128:105-113
16. McCalley DV. Evaluation of the properties of a superficially porous silica stationary phase in hydrophilic interaction chromatography. J Chromatogr A 2008;1193:85-91
17. Cunliffe JM, Maloney TD. Fused-core particle technology as an alternative to sub-2μ m particles to achieve high separation efficiency with low backpressure. J Sep Sci 2007;30:3104-3109
18. MacNair JE, Patel KD, Jorgenson JW. Ultrahigh-pressure reversed-phase capillary liquid chromatography: isocratic and gradient elution using columns packed with 1.0μ m particles. Anal Chem 1999;71:700-708
19. Guillarme D, Russo R, Rudaz S, et al. Chromatographic performance of silica-based stationary phases in high temperature liquid chromatography: pharmaceutical applications. Curr Pharm Anal 2007;4:221-229
20. Cabrera K. Applications of silica-based monolithic HPLC columns. J Sep Sci 2004;27:843-852
21. Nguyen DT, Guillarme D, Rudaz S, Veuthey JL. Fast analysis in liquid chromatography using small particle size and high pressure. J Sep Sci 2006;29:1836-1848
22. Mazzeo JR, Neue UD, Kele M, Plumb RS. A new separation technique takes advantage of sub-2-μ m porous particles. Anal Chem 2005;77:460A-7A
23. Swartz ME. UPLC: an introduction and review. J Liq Chromatogr Relat Technol 2005;28:1253-1263
24. Guillarme D, Nguyen DT, Rudaz S, Veuthey JL. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part I: isocratic separation. Eur J Pharm Biopharm 2007;66:475-482
25. Guillarme D, Nguyen DT, Rudaz S, Veuthey JL. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part II: gradient experiments. Eur J Pharm Biopharm 2008;68:430-440
26. Guillarme D, Grata E, Glauser G, et al. Some solutions to obtain very efficient separations in isocratic and gradient modes using small particles size and ultra-high pressure. J Chromatogr A 2009;1216:3232-3243
27. Grata E, Guillarme D, Glauser G, et al. Metabolite profiling of plant extracts by ultra-high-pressure liquid chromatography at elevated temperature coupled to time-of-flight mass spectrometry. J Chromatogr A 2009;1216:5660-5668
28. Tolonen A, Turpeinen M, Pelkonen O. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Drug Discov Today 2009;14:120-133
29. Howard ML, Hill JJ, Galluppi GR, McLean MA. Plasma Protein Binding in Drug Discovery and Development. Comb Chem High Throughput Screen 2009;13(2)170-187
30. Triolo A, Altamura M, Cardinali F, et al. Mass spectrometry and combinatorial chemistry: a short outline. J Mass Spectrom 2001;36:1249-1259
31. Wang T, Cohen J, Kassel DB, Zeng L. A multiple electrospray interface for parallel mass spectrometric analyses of compound libraries. Comb Chem High Throughput Screen 1999;2:327-334
32. Feher M, Schmidt JM. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 2003;43:218-227
33. Lin Y, Schiavo S, Orjala J, et al. Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Anal Chem 2008;80:8045-8054
34. Abel U, Koch C, Speitling M, Hansske FG. Modern methods to produce natural-product libraries. Curr Opin Chem Biol 2002;6:453-458
35. Liu L, Li YF, Cheng YY. A method for the production and characterization of fractionated libraries from Chinese herbal formulas. J Chromatogr B 2008;862:196-204
36. Glauser G, Guillarme D, Grata E, et al. Optimized liquid chromatography-mass spectrometry approach for the isolation of minor stress biomarkers in plant extracts and their identification by capillary nuclear magnetic resonance. J Chromatogr A 2008;1180:90-98
37. Grata E, Boccard J, Guillarme D, et al. UPLC-TOF-MS for plant metabolomics: a sequential approach for wound marker analysis in Arabidopsis thaliana. J Chromatogr B 2008;871:261-270
38. Quinn RJ, Carroll AR, Pham NB, et al. Developing a drug-like natural product library. J Nat Prod 2008;71:464-468
39. Konkimalla VB, Efferth T. Anti-Cancer Natural Product Library from Traditional Chinese Medicine. Comb Chem High Throughput Screen 2008;11:7-15
40. Faller B, Grimm HP, Loeuillet-Ritzler F, et al. High-throughput lipophilicity measurement with immobilized artificial membranes. J Med Chem 2005;48:2571-2576
41. Carrara S, Reali V, Misiano P, et al. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison. Int J Pharm 2007;345:125-133
42. Mensch J, Noppe M, Adriaensen J, et al. Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early drug discovery. J Chromatogr B 2007;847:182-187
43. Nasal A, Kaliszan R. Progress in the use of HPLC for evaluation of lipophilicity. Curr Comput Aided Drug Des 2006;2:327-340
44. Poole SK, Poole CF. Separation methods for estimating octanol-water partition coefficients. J Chromatogr B 2003;797:3-19
45. Stella C, Galland A, Liu X, et al. Novel RPLC stationary phases for lipophilicity measurement: solvatochromic analysis of retention mechanisms for neutral and basic compounds. J Sep Sci 2005;28:2350-2362
46. Stella C, Seuret P, Rudaz S, et al. Characterization of chromatographic supports for the analysis of basic compounds. J Sep Sci 2002;25:1351-1363
47. Liu X, Tanaka H, Yamauchi A, et al. Lipophilicity measurement by reversed-phase high-performance liquid chromatography (RP-HPLC): a comparison of two stationnary phases based on retention mechanisms. Helv Chim Acta 2004;87:2866-2876
48. Liu X, Tanaka H, Yamauchi A, et al. Determination of lipophilicity by reversed-phase high-performance liquid chromatography. Influence of 1-octanol in the mobile phase. J Chromatogr A 2005;1091:51-59 (Pubitemid 41317565)
49. Benhaim D, Grushka E. Effect of n-octanol in the mobile phase on lipophilicity determination by reversed-phase high-performance liquid chromatography on a modified silica column. J Chromatogr A 2008;1209:111-119
50. Liu X, Hefesha H, Tanaka H, et al. Lipophilicity measurement of drugs by reversed phase HPLC over wide pH range using an alkaline-resistant silica-based stationary phase, XBridge Shield RP(18). Chem Pharm Bull 2008;56:1417-1422
51. Bard B, Carrupt PA, Martel S. Lipophilicity of basic drugs measured by hydrophilic interaction chromatography. J Med Chem 2009;52:3416-3419
52. Valko K, My Du C, Bevan C, et al. Rapid method for the estimation of octanol/water partition coefficient (Log Poct) from gradient RP-HPLC retention and a hydrogen bond acidity term (Sa2H)). Curr Med Chem 2001;8:1137-1146
53. Ayouni L, Cazorla G, Chaillou D, et al. Fast determination of lipophilicity by HPLC. Chromatographia 2005;62:251-255
54. Donovan SF, Pescatore MC. Method for measuring the logarithm of the octanol-water partition coefficient by using short octadecyl-poly(vinyl alcohol) high-performance liquid chromatography columns. J Chromatogr A 2002;952:47-61
55. Welerowicz T, Buszewski B. The effect of stationary phase on lipophilicity determination of beta-blockers using reverse-phase chromatographic systems. Biomed Chromatogr 2005;19:725-736
56. Henchoz Y, Guillarme D, Rudaz S, et al. High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists. J Med Chem 2008;51:396-399
57. Guillot A, Henchoz Y, Moccand C, et al. Lipophilicity determination of highly lipophilic compounds by liquid chromatography. Chem Biodivers 2009;6:1828-1836
58. Camurri G, Zaramella A. High-throughput liquid chromatography/mass spectrometry method for the determination of the chromatographic hydrophobicity index. Anal Chem 2001;73:3716-3722
59. Zhao Y, Jona J, Chow DT, et al. High-throughput logP measurement using parallel liquid chromatography/ultraviolet/mass spectrometry and sample-pooling. Rapid Commun Mass Spectrom 2002;16:1548-1555
60. Kerns EH, Di L, Petusky S, et al. Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography-mass spectrometry. J Chromatogr B 2003;791:381-388
61. Wan H, Ulander J. High-throughput pKa screening and prediction amenable for ADME profiling. Expert Opin Drug Metab Toxicol 2006;2:139-155
62. Kaliszan R, Wiczling P, Markuszewski MJ. pH gradient high-performance liquid chromatography: theory and applications. J Chromatogr A 2004;1060:165-175
63. Chiang PC, Hu Y. Simultaneous Determination of LogD, LogP, and pKa of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injector. Comb Chem High Throughput Screen 2009;12:250-257
64. Escuder-Gilabert L, Martinez-Pla JJ, Sagrado S, et al. Biopartitioning micellar separation methods: modelling drug absorption. J Chromatogr B 2003;797:21-35
65. Taillardat-Bertschinger A, Carrupt PA, Barbato F, Testa B. Immobilized artificial membrane HPLC in drug research. J Med Chem 2003;46:655-665
66. Kotecha J, Shah S, Rathod I, Subbaiah G. Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors. Int J Pharm 2008;360:96-106
67. Yoon CH, Kim SJ, Shin BS, et al. Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography. J Biomol Screen 2006;11:13-20
68. De Jager M, Groenink W, Guivernau R, et al. A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives. Pharm Res 2006;23:951-960
69. Osterberg T, Svensson M, Lundahl P. Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids. Eur J Pharm Sci 2001;12:427-439
70. Molero-Monfort M, Escuder-Gilabert L, Villanueva-Camanas RM, et al. Biopartitioning micellar chromatography: an in vitro technique for predicting human drug absorption. J Chromatogr B 2001;753:225-236
71. Escuder-Gilabert L, Molero-Monfort M, Villanueva-Camanas RM, et al. Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier. J Chromatogr B 2004;807:193-201
72. Martin-Biosca Y, Molero-Monfort M, Sagrado S, et al. Rapid in vitro test to predict ocular tissue permeability based on biopartitioning micellar chromatography. Eur J Pharm Sci 2003;20:209-216
73. Lu R, Sun J, Wang Y, et al. Characterization of biopartitioning micellar chromatography system using monolithic column by linear solvation energy relationship and application to predict blood-brain barrier penetration. J Chromatogr A 2009;1216:5190-5198
74. Yan Z, Caldwell GW. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr Top Med Chem 2001;1:403-425
75. Caldwell GW, Yan Z, Tang W, et al. ADME optimization and toxicity assessment in early-and late-phase drug discovery. Curr Top Med Chem 2009;9:965-980
76. Baranczewski P, Stanczak A, Sundberg K, et al. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol Rep 2006;58:453-472 (Pubitemid 44383272)
77. Nicoli R, Bartolini M, Rudaz S, et al. Development of immobilized enzyme reactors based on human recombinant cytochrome P450 enzymes for phase I drug metabolism studies. J Chromatogr A 2008;1206:2-10
78. Nicoli R, Curcio R, Rudaz S, Veuthey JL. Development of an in-capillary approach to nanoscale automated in vitro cytochromes p450 assays. J Med Chem 2009;52:2192
79. Krylova SM, Okhonina V, Evenhuis CJ, Krylov SN. The Inject-Mix-React- Separate-and-Quantitate (IMReSQ) approach to studying reactions in capillaries. Trends Anal Chem 2009;28:987-1010
80. Plumb RS, Potts WB, Rainville PD, et al. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies. Rapid Commun Mass Spectrom 2008;22:2139-2152
81. Tiller PR, Romanyshyn LA. Liquid chromatography/tandem mass spectrometric quantification with metabolite screening as a strategy to enhance the early drug discovery process. Rapid Commun Mass Spectrom 2002;16:1225-1231
82. Hop CE, Tiller PR, Romanyshyn L. In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry. Rapid Commun Mass Spectrom 2002;16:212-219
83. Guillarme D, Schappler J, Rudaz S, Veuthey JL. Coupling ultra-high pressure liquid chromatography with mass spectrometry. Trend Anal Chem 2010;29:15-27
84. Novakova L, Vlckova H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal Chim Acta 2009;656:8-35
85. Xu R, Manuel M, Cramlett J, Kassel DB. A high-throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry. J Chromatogr A 2010;1217(10):1616-1625
86. Yu K, Di L, Kerns E, et al. Ultra-performance liquid chromatography/ tandem mass spectrometric quantification of structurally diverse drug mixtures using an ESI-APCI multimode ionization source. Rapid Commun Mass Spectrom 2007;21:893-902
87. Schappler J, Nicoli R, Nguyen D, et al. Coupling ultra high-pressure liquid chromatography with single quadrupole mass spectrometry for the analysis of a complex drug mixture. Talanta 2009;78:377-387
88. Rainville PD, Wheaton JP, Alden PG, Plumb RS. Sub one minute inhibition assays for the major cytochrome P450 enzymes utilizing ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2008;22:1345-1350
89. Song W, Pabbisetty D, Groeber EA, et al. Comparison of fused-core and conventional particle size columns by LC-MS/MS and UV: application to pharmacokinetic study. J Pharm Biomed Anal 2009;50:491-500
90. Chauve B, Guillarme D, Cleon P, Veuthey JL. Evaluation of various HILIC materials for the fast separation of polar compounds. J Sep Sci 2010;33:1-13
91. Nguyen HP, Schug KA. The advantages of ESI-MS detection in conjunction with HILIC mode separations: Fundamentals and applications. J Sep Sci 2008;31:1465-1480
92. Plumb R, Castro-Perez J, Granger J, et al. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2004;18:2331-2337
93. Tiller PR, Yu S, Castro-Perez J, et al. High-throughput, accurate mass liquid chromatography/tandem mass spectrometry on a quadrupole time-of-flight system as a 'first-line' approach for metabolite identification studies. Rapid Commun Mass Spectrom 2008;22:1053-1061
94. Castro-Perez J, Plumb R, Granger JH, et al. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 2005;19:843-848
95. Crockford DJ, Maher AD, Ahmadi KR, et al. 1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies. Anal Chem 2008;80:6835-6844
96. Bateman KP, Castro-Perez J, Wrona M, et al. MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun Mass Spectrom 2007;21:1485-1496
97. Noga M, Sucharski F, Suder P, Silberring J. A practical guide to nano-LC troubleshooting. J Sep Sci 2007;30:2179-2189
98. Yin H, Killeen K, Brennen R, et al. Microfluidic chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip. Anal Chem 2005;77:527-533
99. Vollmer M, Buckenmaier S. Using nanospray HPLC-CHIP/TOF for routine high sensitivity metabolite identification. Agilent technologies application note. 2006:5989-5938EN
100. Guillarme D, Ruta J, Rudaz S, Veuthey JL. New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches: published online, doi: 10 1007/s00216-009-3305-3308 2010